SCOLARI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 18.828
EU - Europa 16.045
AS - Asia 12.521
SA - Sud America 3.010
AF - Africa 216
OC - Oceania 63
Continente sconosciuto - Info sul continente non disponibili 26
Totale 50.709
Nazione #
US - Stati Uniti d'America 18.525
PL - Polonia 5.835
CN - Cina 4.061
SG - Singapore 3.795
UA - Ucraina 3.590
BR - Brasile 2.563
IT - Italia 2.213
HK - Hong Kong 2.001
DE - Germania 1.381
VN - Vietnam 1.014
FI - Finlandia 803
TR - Turchia 559
IE - Irlanda 494
GB - Regno Unito 476
RU - Federazione Russa 470
FR - Francia 305
IN - India 197
AR - Argentina 196
JP - Giappone 163
CA - Canada 152
ID - Indonesia 148
BD - Bangladesh 145
NL - Olanda 131
MX - Messico 100
IQ - Iraq 94
SE - Svezia 74
EC - Ecuador 72
ZA - Sudafrica 68
AU - Australia 61
CO - Colombia 49
AT - Austria 47
PK - Pakistan 46
MA - Marocco 43
ES - Italia 40
CZ - Repubblica Ceca 34
PY - Paraguay 34
SA - Arabia Saudita 34
UZ - Uzbekistan 30
VE - Venezuela 30
EG - Egitto 25
EU - Europa 25
BE - Belgio 24
JO - Giordania 24
CL - Cile 23
IR - Iran 23
PE - Perù 22
CH - Svizzera 19
KE - Kenya 19
MY - Malesia 19
AZ - Azerbaigian 17
LT - Lituania 16
KZ - Kazakistan 15
TW - Taiwan 15
KR - Corea 13
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
IL - Israele 12
LV - Lettonia 12
NP - Nepal 12
TN - Tunisia 11
AL - Albania 10
ET - Etiopia 10
KG - Kirghizistan 10
RO - Romania 10
DZ - Algeria 9
PA - Panama 9
DO - Repubblica Dominicana 8
MU - Mauritius 8
PS - Palestinian Territory 8
TH - Thailandia 8
BO - Bolivia 7
HU - Ungheria 7
OM - Oman 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
AM - Armenia 6
BG - Bulgaria 6
HN - Honduras 6
LB - Libano 6
PH - Filippine 6
RS - Serbia 6
GR - Grecia 5
JM - Giamaica 5
MK - Macedonia 5
BW - Botswana 4
CR - Costa Rica 4
GT - Guatemala 4
KW - Kuwait 4
LU - Lussemburgo 4
NO - Norvegia 4
UG - Uganda 4
BB - Barbados 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
HR - Croazia 3
KH - Cambogia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
Totale 50.673
Città #
Warsaw 5.816
Jacksonville 2.272
Fairfield 2.014
Woodbridge 1.999
Hong Kong 1.980
Singapore 1.845
Ashburn 1.229
Houston 1.181
Princeton 970
Ann Arbor 928
Cambridge 869
Beijing 808
Wilmington 770
Seattle 749
Nanjing 726
Dublin 487
Istanbul 442
Chandler 401
The Dalles 398
Los Angeles 343
Helsinki 323
Ho Chi Minh City 311
Nanchang 295
New York 294
Milan 252
Des Moines 237
Dong Ket 216
Buffalo 205
São Paulo 200
Moscow 199
Redondo Beach 185
Changsha 184
Shenyang 177
Hebei 176
Brescia 159
Hanoi 141
Munich 131
Dearborn 127
San Diego 115
Tianjin 115
Jiaxing 109
Dallas 97
Shanghai 95
Hangzhou 93
Rio de Janeiro 93
Jinan 90
Chicago 87
Council Bluffs 87
Rome 78
Verona 78
Phoenix 76
San Francisco 76
Jakarta 72
Tokyo 61
Toronto 61
Kocaeli 60
Kunming 57
London 57
Nuremberg 54
Brooklyn 49
Santa Clara 48
Belo Horizonte 46
Montreal 43
Guangzhou 41
Lanzhou 41
Brasília 40
Ningbo 38
Turku 35
Zhengzhou 35
Redwood City 34
Baghdad 33
Curitiba 33
Melbourne 33
Porto Alegre 33
Campinas 30
Denver 30
Norwalk 30
Atlanta 29
Dhaka 28
Haiphong 28
San Mateo 28
Da Nang 27
Brno 26
Orem 26
Palermo 26
Tashkent 26
Augusta 25
Vienna 25
Amman 24
Johannesburg 24
Taizhou 24
Bologna 23
Boston 23
Chennai 23
Frankfurt am Main 23
Biên Hòa 22
Düsseldorf 22
Erbil 22
Guarulhos 22
Quito 22
Totale 32.990
Nome #
Trattamento del linfocele postoperatorio mediante instillazione su guida ecografica di polivinil-pirrolidone iodico. Casistica personale. 871
The pathophysiology of IgA nephropathy 602
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 396
Genome-wide association study identifies susceptibility loci for IgA nephropathy 372
GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway 275
Genetic drivers of kidney defects in the digeorge syndrome 270
The copy number variation landscape of congenital anomalies of the kidney and urinary tract. 261
Insufficienza renale acuta e o subacuta richiedente dialisi in corso di malattia ateroembolica renale: impatto sulla sopravvivenza del paziente e del rene. 258
Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) 256
Suprarenal aortic cross-clamping in the elective surgery of abdominal aortic aneurysms. Lessons from 68 cases out of consecutive survey of 746 abdominal aortic substitutions. 251
Autoimmunity in membranous nephropathy targets aldose reductase and SOD2 244
Lack of association between dialysis modality and outcomes in atheroembolic renal disease 236
PREDICTORS OF RENAL AND PATIENT OUTCOMES IN ATHEROEMBOLIC RENAL DISEASE: A PROSPECTIVE STUDY. 233
The importance of skin biopsy in the diverse clinical manifestations of cholesterol embolism. 232
A recessive gene for primary vesicoureteral reflux maps to chromosome 12p11-q13. 231
Familial aggregation of primary glomerulonephritis in an Italian population isolate: Valtrompia study 230
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. 229
The Case | Cystic renal disease, nephrogenic diabetes insipidus, and polycytemia. 228
Defective intracellular trafficking of uromodulin mutant isoforms 227
Malattia cistica della midollare (MCKD), Nefropatia iperuricemica familiare giovanile (FJHN) e Glomerulocisti (GCKD) sono causate da mutazioni dello stesso gene (UMOD) che determinano alterazioni del trasporto cellulare di uromodulina. 226
Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study 224
Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin 223
Uromodulin storage diseases: clinical aspects and mechanisms. 222
IgA nephropathy: the presence of familial disease does not confer an increased risk for progression 220
The rediscovery of uromodulin (Tamm-Horsfall protein): from tubulointerstitial nephropathy to chronic kidney disease. 220
Autosomal Dominant tubulointerstitial Kidney Disease with Adult onset due to a novel Renin Mutation Mapping in the Mature protein 219
Genetic studies of IgA nephropathy: past, present, and future. 218
Exome sequencing identified MYO1E and NEIL1 as candidate genes for human autosomal recessive steroid-resistant nephrotic syndrome. 218
Genetic heterogeneity in Italian families with IgA nephropathy: suggestive linkage for two novel IgA nephropathy loci. 217
Coexistence of Different Circulating Anti-PodocyteAntibodies in Membranous Nephropathy 217
Mutations in DSTYK and dominant urinary tract malformations. 216
Infertility and hypergonadotropic hypogonadism as first evidence of hereditary apolipoprotein A-I amyloidosis 215
IgA nephropathy--the case for a genetic basis becomes stronger. 214
CHOLESTEROL CRYSTAL EMBOLISM: A RECOGNIZABLE CAUSE OF RENAL DISEASE 213
Familial vesicoureteral reflux: testing replication of linkage in seven new multigenerational kindreds 212
Clinical features and long-term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations. 211
Genetic approaches to human renal agenesis/hypoplasia and dysplasia. 210
Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families 210
Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritis 209
Renal outcome in patients with congenital anomalies of the kidney and urinary tract. 205
Urinary secretion and extracellular aggregation of mutant uromodulin isoforms 205
Search for genetic association between IgA nephropathy and candidate genes selected by function or by gene mapping at loci IGAN2 and IGAN3 205
Atheroembolic renal disease 204
IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23 203
Localization of a gene for nonsyndromic renal hypodysplasia to chromosome 1p32-33. 203
Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. 200
The Case ∣ Familial occurrence of retinitis pigmentosa, deafness, and nephropathy. 198
Copy number disorders are a Common Cause of Congenital Kidney Malformations 196
Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial. 196
Cis and trans regulatory elements in NPHS2 promoter: implications in proteinuria and progression of renal diseases 195
Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection. 194
Phenotypic expansion of DGKE-associated diseases. 193
Glomerular autoimmune multicomponents of human lupus nephritis in vivo: α-enolase and annexin AI 184
Glomerular Autoimmune Multicomponents of Human Lupus Nephritis In Vivo (2): Planted Antigens. 183
A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation. 174
The progression from obesity to type 2 diabetes in Alström syndrome. 174
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens 174
A model to predict disease progression in patients with autosomal dominant polycystic kidney disease (ADPKD): the ADPKD Outcomes Model 172
Glomerular clusterin is associated with PKC-alpha/beta regulation and good outcome of membranous glomerulonephritis in humans 169
Anemia emolitica autoimmune acquisita (AEAA) da incompatibilità minore ABO: un raro esempio di graft versus host disease (GVHD) in corso di trapianto di rene (TX). 169
A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. 168
Uromodulin: from monogenic to multifactorial diseases. 167
LES FORMES FAMILIALES DE NÉPHROPATHIE À IgA ÉTUDES CLINIQUE ET GÉNÉTIQUE 166
Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome. 165
AUTOSOMAL DOMINANT MEDULLARY CYSTIC KIDNEY DISEASE 165
ORO-FACIO-DIGITAL SYNDROME 164
Berger's Disease 161
IDENTIFICATION OF A NEW LOCUS FOR MEDULLARY CYSTIC DISEASE ON CHROMOSOME 16 158
A large TSC2 and PKD1 gene deletion is associated with renal and extrarenal signs of autosomal dominant polycystic kidney disease 154
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 151
Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis. 149
Myroides odoratimimus urinary tract infection in an immunocompromised patient: An emerging multidrug-resistant micro-organism 148
A long term, randomized clinical trial to evaluate the effects of ramipril on the evolution of renal function in chronic nephropathies. 147
Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure. 147
Non-collagen genes role in digenic Alport syndrome 147
The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors 144
Antiphospholipid syndrome and glomerular thrombosis in the absence of overt lupus nephritis 143
Familial IgM mesangial nephropathy: a morphologic and immunogenetic study of three pedigrees. 143
A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection 139
Early histopathologic changes predicting long-term kidney transplant survival. 138
Clustering familiare di differenti forme di glomerulonefrite primitiva: studio Valtrompia: 136
La sindrome oro-facio-digitale tipo 1: una causa infrequente di malattia cistica renale a carattere ereditario. 135
Immunogenetics of Henoch-Schoenlein disease. 134
Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial. 132
An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes 131
Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. 130
Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. 130
Familial occurrence of primary glomerulonephritis: evidence for a role of genetic factors. 129
Viral hepatitis in HBsAg-positive renal transplant patients treated with cyclosporin and steroids. 128
Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition. 128
Rare functional variants of podocin (NPHS2) promoter in patients with nephrotic syndrome 126
Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. 126
Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens. 125
Are HLA class II and immunoglobulin constant region genes involved in the pathogenesis of mixed cryoglobulinemia type II after hepatitis C virus infection? 125
Utilità della scintigrafia con 99mTC solofo-colloide nella diagnosi di rigetto del rene trapiantato. 125
32 cases of familial primary glomerulonephritis: HLA do not play a role in the genetic mechanism of the disease. 125
Atheroembolic renal disease. 125
Apolipoprotein E in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. 124
Spermatogenic and steroidogenic impairment of the testicle characterizes the hereditary leucine-75-proline apolipoprotein a-I amyloidosis. 124
The IgA nephropathy Biobank. An important starting point for the genetic dissection of a complex trait 124
Totale 19.858
Categoria #
all - tutte 229.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 229.331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.033 0 0 0 0 0 1.086 292 967 1.003 680 674 331
2021/20223.095 134 746 27 101 55 94 171 202 172 339 284 770
2022/20231.966 518 20 32 102 118 644 6 146 193 17 89 81
2023/20242.787 104 49 153 244 77 274 122 80 1.022 45 63 554
2024/20257.332 48 46 53 839 965 576 996 200 721 386 1.588 914
2025/20269.651 1.275 2.311 1.457 2.628 1.215 765 0 0 0 0 0 0
Totale 51.261